Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages

Hsiao Wen Lin, E. Jian Lee

研究成果: Review article同行評審

35 引文 斯高帕斯(Scopus)

摘要

Melatonin (N-acetyl-5-methoxy-tryptamine), a naturally occurring indole produced mainly by the pineal gland, is a well known antioxidant. Stroke (cerebral ischemia) is the second leading cause of death worldwide. To date, however, effective and safe treatment for stroke remains unavailable. Melatonin is both lipid- and water-soluble and readily crosses the blood-brain barrier (BBB). Increasing evidence has shown that, in animal stroke models, administering melatonin significantly reduces infarct volume, edema, and oxidative damage and improves electrophysiological and behavioral performance. Here, we reviewed studies that assess effects of melatonin on cerebral ischemia in acute, sub-acute, and chronic stages. In addition to its potent antioxidant properties, melatonin exerts antiapoptotic, antiexcitotoxic, anti-inflammatory effects and promotes mitochondrial functions in animals with cerebral ischemia. Given that melatonin shows almost no toxicity to humans and possesses multifaceted protective capacity against cerebral ischemia, it is valuable to consider using melatonin in clinical trials on patients suffering from stroke.

原文English
頁(從 - 到)157-162
頁數6
期刊Neuropsychiatric Disease and Treatment
5
發行號1
DOIs
出版狀態Published - 2009

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Biological Psychiatry

指紋 深入研究「Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages」主題。共同形成了獨特的指紋。

引用此